other · Healthcare · Biotechnology
PGEN
5.49+0.42 +8.28%Past year
Loading chart…
Loading financials…
Company snapshot
- Ticker
- PGEN
- Exchange
- NMS
- Sector
- Healthcare
- Industry
- Biotechnology
- Market cap
- $1.83B
- Employees
- 160
- Currency
- USD
- Website
- https://precigen.com
Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases. The company offers therapeutic platforms consisting of AdenoVerse platform, which utilizes a library of proprietary adenovectors for gene delivery of therapeutic effectors, immunomodulators, and vaccine antigen; and UltraCAR-T to provide chimeric antigen receptor…
Latest coverage
No coverage yet — articles appear here automatically as press releases are published.
Related other stocks
Quotes & data
Follow Precigen, Inc. (PGEN) across major market-data sources.